APAP 325 mg / Chlorpheniramine Maleate 1 mg / Guaifenesin 25 mg / Phenylpropanolamine Hydrochloride 12.5 mg Oral Tablet
RxNorm 2283241
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2283241 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: APAP 325 mg / Chlorpheniramine Maleate 1 mg / Guaifenesin 25 mg / Phenylpropanolamine Hydrochloride 12.5 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Acetaminophen 325 mg / chlorpheniramine maleate 1 mg / guaifenesin 25 mg / phenylpropanolamine hydrochloride 12.5 mg Oral Tablet
(Atom ID: 12334877)
TMSY
Tall Man Lettering Synonym (TMSY):
Acetaminophen 325 mg / chlorpheniramine maleate 1 mg / guaiFENesin 25 mg / phenylpropanolamine hydrochloride 12.5 mg Oral Tablet
(Atom ID: 12382349)
SY
Synonym (SY):
APAP 325 mg / chlorpheniramine maleate 1 mg / guaifenesin 25 mg / phenylpropanolamine HCl 12.5 mg Oral Tablet
(Atom ID: 11834427)
TMSY
Tall Man Lettering Synonym (TMSY):
APAP 325 mg / chlorpheniramine maleate 1 mg / guaiFENesin 25 mg / phenylpropanolamine HCl 12.5 mg Oral Tablet
(Atom ID: 11834997)
SY
Synonym (SY):
APAP 325 mg / Chlorpheniramine Maleate 1 mg / Guaifenesin 25 mg / Phenylpropanolamine Hydrochloride 12.5 mg Oral Tablet
(Atom ID: 11834912)
TMSY